Peter Y. Tam President

Peter Y. Tam has served as our President and a Director since October 2009. From January 2009 until October 2009, Mr. Tam served as our Chief Operating Officer. From July 2004 to January 2009, Mr. Tam served as Senior Vice President of Product and Corporate Development of the company. From November 2002 to July 2004, Mr. Tam served as our Vice President of Strategic Planning and Corporate Development. Mr. Tam joined the company in 1993 as Manager of Clinical Research and in 1999 he assumed the responsibilities of Director of Clinical and Corporate Development. Mr. Tam holds a B.S. in Chemistry from University of California Berkeley and an M.B.A. from Santa Clara University.

Ted Broman Vice President, Chemistry, Manufacturing and Control

Mr. Broman has been Vice President, Chemistry, Manufacturing and Control since February 2009. Mr. Broman joined VIVUS in January 2006 as Senior Director, Chemistry, Manufacturing, and Control. Prior to joining VIVUS, Mr. Broman was Executive Director, Project Management at Durect, Inc. from 2001 to 2005. From 1994 to 2001, Mr. Broman held Senior Management positions in Operation and Project Management at Matrix Pharmaceutical, Inc. From 1988 to 1994 he was Director, Analytical Services at Cygnus, Inc. and from 1976 to 1988, Mr. Broman served in several positions in Syntex Laboratories, Syntex Chemicals Group, Corporate Quality Assurance, and Corporate Technical Services. Mr. Broman has a B.A. in Biochemistry and Molecular Biology from the University of California, Santa Barbara.

Wesley W. Day, Ph.D. Vice President, Clinical Development

Dr. Day has been the Vice President of Clinical Development since November 2005. Prior to joining VIVUS, Dr. Day held a variety of positions with Pfizer, Inc. from 1993 until his departure in October 2005. Most recently, Dr. Day was the Senior Director, Safety Risk Management from September 2003 until his departure. Prior to this position, Dr. Day served as the Senior Associate Director, Worldwide Regulatory Affairs from August 2001 to 2003, Associate Director II, Worldwide Regulatory Affairs from 2000 to 2001, Associate Director I, Clinical Development from 1999 to 2000, Senior Clinical Research Investigator from 1997 to 1998, Senior Research Scientist from 1995 to 1997 and Research Scientist from 1993 to 1994. Dr. Day holds a Ph.D. in Pharmacology and Toxicology from the University of Maryland at Baltimore, a B.S. with Highest Honors from the University of Texas at Pan American. Dr. Day is an Adjunct Associate Professor for the School of Pharmacy at the University of Maryland at Baltimore where he has held an Adjunct Appointment since 1995. He has also been an Adjunct Assistant Professor for Temple University.

Guy P. Marsh Vice President of U.S. Operations & General Manager

Mr. Marsh has been Vice President of U.S. Operations and General Manager for VIVUS since July 2000. Mr. Marsh joined VIVUS in May 1998 in the position of Senior Director, U.S. Operations, and assumed the responsibilities of General Manager, Operations in April 1999. Prior to joining VIVUS, Mr. Marsh served as Vice President Technical Operations for Copley Pharmaceutical, Inc. from April 1994 to April 1998. Also during this period, Mr. Marsh served as a liaison between Copley Pharmaceutical and Copley’s Majority Stockholder, Hoechst-Celanese Corporation. From November 1987 to April 1994, Mr. Marsh served in various Manufacturing, Sales and Business Management roles for Hoechst-Roussel Pharmaceuticals, Inc. Mr. Marsh received a B.S. in Engineering from New Jersey Institute of Technology, holds a New Jersey State Professional Engineering License, and received an MBA from Seton Hall University.

Malcolm McKay, Ph.D. Vice President, Regulatory Affairs

Dr. McKay has served as the company’s Vice President, Regulatory Affairs since June 2010. Dr. McKay has over 25 years of compliance experience covering all aspects of pharmaceutical drug development and commercialization. Prior to joining the company, Dr. McKay was self-employed as a Pharmaceutical Development and Compliance Consultant. Dr. McKay previously served as the Vice President Corporate Compliance with InterMune, Inc. from 2003 to 2007, the Vice President of Quality and Regulatory Affairs with Cell Genesys from 2000 to 2003 and was Vice President Regulatory Affairs with Celtrix Pharmaceuticals from1996 to 2000. Dr. McKay has a PhD in Biochemistry from University of London.

Michael P. Miller Senior Vice President, Chief Commercial Officer

Michael P. Miller has been Senior Vice President and Chief Commercial Officer since April 2010. From February 2006 to April 2010, Mr. Miller served as Vice President and Franchise Head in the BioOncology Business Unit at Genentech, a wholly owned member of the Roche Group. Before that, Mr. Miller was Senior Vice President and Chief Commercial Officer of Connetics Corporation. He also served as Vice President at ALZA Corporation, a Johnson & Johnson Company. Prior to ALZA, Mr. Miller held Senior Sales and Marketing Executive positions at VIVUS and Syntex Laboratories. Mr. Miller holds a BS from the University of San Francisco and an MBA from San Francisco State University.

Timothy E. Morris Senior Vice President, Finance & Chief Financial Officer

Timothy E. Morris has been with VIVUS since November 2004 and currently serves as Senior Vice President Finance and Global Corporate Development, Chief Financial Officer. Prior to joining VIVUS, Mr. Morris served as member of the Office of the President, Chief Financial Officer and Senior Vice President of Finance & Administration at Questcor Pharmaceuticals Inc. from September 2001 to November 2004. Prior to this position, Mr. Morris served as Vice President of Finance & Administration and Chief Financial Officer at RiboGene, Inc., the predecessor company to Questcor, from May 1995 to October 1999. Prior to RiboGene, Mr. Morris was at Glycomed Incorporated from May 1992 to May 1995 most recently as Chief Accounting Officer, acting Chief Financial Officer and Senior Director, Finance. Mr. Morris earned a BS degree, cum laude, in Business with an emphasis in Accounting from California State University, Chico, and in 1986 Mr. Morris became a certified public accountant.

Lee B. Perry Vice President and Chief Accounting Officer

Mr. Perry has served as the company's Vice President and Chief Accounting Officer since February 2007. His responsibilities include oversight of the company's accounting operations and systems, external reporting, financial planning and analysis, cost accounting, internal controls, taxation and risk management. Mr. Perry has over 30 years experience in Corporate Finance and Operations and Public Accounting. For the past twenty years he has held Senior Financial positions in Life Sciences and Manufacturing Industries. Prior to VIVUS, his life science experience included serving as Senior Director of Finance at Questcor Pharmaceuticals, Inc. and as Director of Finance at DNA Sciences, Inc. Mr. Perry also served as Chief Financial Officer of BHP Coated Steel, Corp. Mr. Perry earned his BA degree in Economics from San Diego State University and is a certified public accountant.

John L. Slebir, Esq. Vice President Business Development and General Counsel

Mr. Slebir has been our Vice President, Business Development and General Counsel since June 2011 and General Counsel since April 2010. Prior to joining VIVUS, Mr. Slebir was an attorney at Wilson Sonsini Goodrich & Rosati from 1999 to 2010, where he specialized in representing public and private companies on corporate and securities matters, including corporate governance, securities law compliance, public and private financings and mergers and acquisitions. From 1991 to 1999, Mr. Slebir was an attorney at Hancock, Rothert & Bunshoft and Ropers, Majeski, Kohn & Bentley, where he specialized in commercial litigation. Mr. Slebir holds a J.D. from Santa Clara University School of Law, and received his B.A. degree in Communications from San Diego State University.

Barbara Troupin, MD, MBA Vice President, Scientific Communications and Risk Management

Barbara Troupin, MD, MBA, Vice President, Scientific Communication & Risk Management. Dr. Troupin has been the Vice President of Scientific Communication and Risk Management since February 2012. Prior to her current role, she held Senior Director roles in Medical Affairs and in Clinical Development at VIVUS, initially joining the company in April 2006. Before joining VIVUS, Dr. Troupin was the Medical Director for Profil Institute for Clinical Research in San Diego, a niche phase 1 site focused on complex clinical trials in diabetes and obesity. Prior to that she was the Medical Director for Radiant Research in San Diego for 5 years and was the Principal Investigator on more than 150 cardiovascular and metabolic clinical studies. Dr. Troupin holds an M.D. from the University of Pennsylvania and an MBA from the Wharton School of Business, and is a licensed and boarded family physician.

Santosh T. Varghese, MD Vice President, Head of Medical Affairs and Pharmacovigilance

Dr. Varghese has been the company’s Vice President, Medical Affairs since March 2012, with additional responsibility over Pharmacovigilance. Prior to joining the company, Dr. Varghese was Senior Vice President, Medical Affairs at Elan Pharmaceuticals where he lead Medical Affairs teams responsible for the BioNeurology portfolio. He held the position of Vice President Primary Care & Cardiovascular in Global Medical Affairs at Schering-Plough/Merck and also held Senior roles at Aventis/Sanofi-Aventis where he contributed to both US & Global Brand Strategy and Tactics. Dr. Varghese has served on the Board of Directors of the American Lung Association - New York, is currently on the Board of Directors of the non-profit Corban Group Corporation, and was on faculty at Touro University College of Medicine. Dr. Varghese earned his M.D. from St. George’s University School of Medicine, and B.S. in Biology from Pennsylvania State University. He completed his medical training in the Caribbean, United States, and United Kingdom.